Sector pending / General Medical and Surgical HospitalsUpdated 2026-05-10 22:07 UTC

KLSE/SUNMED stock hub

KLSE/SUNMED has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KLSE/SUNMEDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

21.6B

Bursa Malaysia

Market data

Live price

Current market quote for this ticker.

Current price

KLSE/SUNMED

In the news

Latest news · KLSE/SUNMED

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E74.2

P25 n/aP50 n/aP75 n/a

Trailing P/E85.8

P25 n/aP50 n/aP75 n/a

ROE9.3

P25 n/aP50 n/aP75 n/a

ROIC7.8

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KLSE/SUNMED market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

150

Groups with data

Currency

MYR

Showing 150 of 150 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Malaysia
Country code	MY
Enterprise value	MYR 22.7B
Exchange	Bursa Malaysia
Financial currency	MYR
First seen	2026-05-10
Industry	General Medical and Surgical Hospitals
Last refreshed	2026-05-10
Market cap	MYR 21.6B
Price	MYR 1.88
Price currency	MYR
Sic	8062
Symbol	klse/SUNMED
Website	https://www.sunwayhealthcaregroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.17%
EV Earnings	89.81x
EV/EBIT	76.12x
EV/EBITDA	46.56x
EV/FCF	-205.26x
EV/Sales	10.29x
FCF yield	-0.51%
Forward P/E	74.25x
P/B ratio	8.58x
P/E ratio	85.85x
P/S ratio	9.83x
PEG ratio	3.75x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	13.52%
EBITDA Margin	21.7%
Gross margin	62.87%
Gross Profit	MYR 1.4B
Gross Profit Growth	109.18%
Net Income	MYR 252.2M
Net Income Growth	20.16%
Pretax Margin	12.46%
Profit Margin	11.46%
ROA	3.91
ROCE	7.62
ROE	9.32
ROIC	7.81

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth	14.06
OCF Growth	135%
Revenue Growth	106.65x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	MYR 0.46
Assets	MYR 4.8B
Cash	MYR 586.4M
Current Assets	MYR 1.1B
Current Liabilities	MYR 936.5M
Debt	MYR 1.6B
Debt EBITDA	MYR 3.32
Debt Equity	MYR 0.64
Debt FCF	MYR -14.65
Equity	MYR 2.5B
Interest Coverage	5.03
Liabilities	MYR 2.3B
Long Term Assets	MYR 3.8B
Long Term Liabilities	MYR 1.4B
Net Cash	MYR -1B
Net Cash By Market Cap	MYR -4.77
Net Debt EBITDA	MYR 2.16
Net Debt Equity	MYR 0.41
Tangible Book Value	MYR 2.5B
Tangible Book Value Per Share	MYR 0.22

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.13
Inventory Turnover	9.37
Net Working Capital	MYR -153.2M
Quick ratio	1.01
Working Capital	MYR 122M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-5.26%
Payout Ratio	246.82%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
All Time High	2.46
All Time High Change	-23.58%
All Time High Date	2026-03-27
All Time Low	1.45
All Time Low Change	29.66%
All Time Low Date	2026-03-16
ATR	0.07
Beta1y	-1.65
High	1.89
High52	2.46
High52 Date	2026-03-27
High52ch	-23.58%
Low	1.86
Low52	1.45
Low52 Date	2026-03-17
Low52ch	29.66%
RSI	57.16
RSI Monthly	0
RSI Weekly	0
Sharpe ratio	2.37x
Sortino ratio	5.44
Total Return	-5.26%
Tr1m	-0.53%
Tr1w	-0.53%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	MYR 297.6M
Operating Income Growth	52.94
Operating margin	13.52

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,228,538,541%
Net Borrowing	515,362,000
Shares Insiders	0.11%
Shares Institutions	6.21%
Shares Out	11,500,165,558
Shares Qo Q	-32.14%
Shares Yo Y	5.26%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	MYR -110.4M
Average Volume	27,218,335x
Bv Per Share	0.22
CAPEX	MYR -576M
Ch1m	-0.53
Ch1w	-0.53
Change	0.53%
Change From Open	0.53
Close	1.87
Days Gap	0
Depreciation Amortization	179,843,000
Dollar Volume	15,004,656
Earnings Date	2026-05-20
EBIT	MYR 297.6M
EBITDA	MYR 477.4M
EPS	MYR 0.02
F Score	6
FCF	MYR -110.4M
FCF EV Yield	-0.49x
FCF Per Share	MYR -0.01
Financing CF	-137,854,000
Fiscal Year End	December
Founded	2,021
Goodwill	2,349,000
Graham Number	0.32863
Graham Upside	-82.52
Income Tax	MYR 22M
Investing CF	-551,515,000
Is Primary Listing	1
Last Report Date	2025-12-31
Ma20	1.88
Ma20ch	0.05%
Net CF	-224,677,000
Next Earnings Date	2026-05-20
Open	1.87
P OCF Ratio	46.43
Position In Range	66.67
Ppne	3,676,463,000
Price Date	2026-05-08
Price EBITDA	MYR 45.29
Ptbv Ratio	8.7
Relative Volume	0.29x
Revenue	2,200,389,000x
Tax By Revenue	1x
Tax Rate	8.03%
Volume	7,981,200
Z Score	0.79

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does KLSE/SUNMED pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns KLSE/SUNMED?

Insider, institutional, and short-interest positioning.

Institutional ownership

+6.2%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+5.3%

Negative means the company is buying back shares.

Technical

KLSE/SUNMED momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

57.2

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

2.37

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KLSE/SUNMED

Hub-level FAQ points readers to the deeper analysis pages.

What is the current klse/SUNMED stock rating?

klse/SUNMED is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full klse/SUNMED analysis?

The full report lives at /stocks/klse/SUNMED/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for klse/SUNMED?

The latest report frames klse/SUNMED around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the klse/SUNMED page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.